ea0029p1398 | Pituitary Clinical | ICEECE2012
Urbani C.
, Calevro A.
, Scattina I.
, Lombardi M.
, Sardella C.
, Nuzzo A.
, Marchello A.
, Martino E.
, Bogazzi F.
Introduction: Acromegaly is associated with alterations of glucose metabolism. The effect of somatostatin analogues (SMS) and pegvisomant (PEG) on glucose metabolism is still argument of debate.Study design: The purpose of this historical-prospective study was to compare, in a cohort of 47 patients with active acromegaly, the effects of SMS and PEG alone or in combination on glucose metabolism. All subjects were evaluated at baseline and at least 6 month...